Erythropoietin Stimulating Agents & Intravenous Iron
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £8M-£12M
- Sector
- HEALTH
- Published
- 05 Nov 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
1 buyer
- NHS National Services Scotland NSS Edinburgh
5 suppliers
- Vifor Pharma Bagshot
- Pharmacosmos Reading
- Roche Products Welwyn Garden City
- Pfizer Tadworth
- Amgen Cambrdige
Description
Supply of Erythropoietin Stimulating Agents & Intravenous Iron to NHS Scotland. The Goods have been split into two (2) categories, each of which are identified as a “Lot”. Full details of each Lot are contained in section II.2 of this notice.
Lot Division
1 | Intravenous Iron Supply of Intravenous Iron to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per line. |
2 | Erythropoietin Stimulating Agents Supply of Erythropoietin Stimulating Agents to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per line. |
Award Detail
1 | Vifor Pharma (Bagshot)
|
2 | Pharmacosmos (Reading)
|
3 | Roche Products (Welwyn Garden City)
|
4 | Pfizer (Tadworth)
|
5 | Amgen (Cambrdige)
|
Award Criteria
Supply Chain | 5 |
price | 95 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.1.7 & V.2.4 cover(s) the twenty-four (24) month contract duration and the twenty-four (24) month extension period of the framework agreement. (SC Ref:671906)
Reference
- ocds-h6vhtk-02ccf4
- FTS 027774-2021